首页 | 本学科首页   官方微博 | 高级检索  
检索        

抗人喉癌/抗CD3双功能抗体的制备及对Hep-2细胞株的杀伤作用
引用本文:冯青杰,闫世军,孙立群,吴东辉.抗人喉癌/抗CD3双功能抗体的制备及对Hep-2细胞株的杀伤作用[J].中国免疫学杂志,2003,19(5):359-360.
作者姓名:冯青杰  闫世军  孙立群  吴东辉
作者单位:吉林大学第二医院,长春,130041
摘    要:目的:研究制备抗人喉癌/抗CD3双功能抗体,探讨喉癌主动免疫治疗。方法:以化学方法将人喉癌及抗CD3单克隆抗体交联为双功能抗体,进行介导对肿瘤细胞的杀伤作用。结果:该双功能抗体介导效应细胞对靶细胞的杀伤率高于抗CD3的介导作用,并随着效靶比的提高而升高。结论:采用化学交联法制备的抗人喉癌/CD3双功能抗体具有潜在的临床应用价值。

关 键 词:喉癌  抗CD3  双功能抗体  制备  Hep-2细胞株  杀伤作用
文章编号:1000-484X(2003)05-0359-02

The preparation and the killer function on Hep-2 clone of bifunction antibody of anti-human laryngocarcinoma/anti-CD3
FENG Qing-Jie,YAN Shi-Jun,SUN Li-Qun et al.Second Clinical College of Jilin University,Changchun ,China.The preparation and the killer function on Hep-2 clone of bifunction antibody of anti-human laryngocarcinoma/anti-CD3[J].Chinese Journal of Immunology,2003,19(5):359-360.
Authors:FENG Qing-Jie  YAN Shi-Jun  SUN Li-Qun Second Clinical College of Jilin University  Changchun  China[
Institution:FENG Qing-Jie,YAN Shi-Jun,SUN Li-Qun et al.Second Clinical College of Jilin University,Changchun 130041,China[
Abstract:Objective:To prepare bifunction antibody of anti-human laryngocarcinoma/anti-CD 3 for the active immune therapy of laryngocarcinoma.Methods:To corss link monoclonal antibody of anti-human laryngocarcinoma and anti-CD 3 into bifunction antibody by chemical method,which can guide the killer function on carcinoma cells.Results:The killer rate of effector cells guided by bifunction antibody is higher than that of anti-CD 3 which can arise with the elevation of effect target ratio.Conclusion:Bifunction antibody of anti-human laryngocarcinoma/anti-CD 3 prepared by chemical cross linking method has the potential value for clinical application.
Keywords:Laryngocarcinoma  Anti-CD  3  Bifunction antibody
本文献已被 CNKI 维普 万方数据 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号